Waypoint Bio
- Biotech or pharma, therapeutic R&D

Waypoint Bio is building ex vivo & in vivo cell therapies for solid tumors using in vivo pooled screening with spatial biology.
June 16-19, 2025
Boston Convention & Exhibition Center
Waypoint Bio is building ex vivo & in vivo cell therapies for solid tumors using in vivo pooled screening with spatial biology.